NEWARK - The New Jersey State Board of Pharmacy today announced a Second Voluntary Interim Consent Order with Med Prep Consulting Inc., a compounding pharmacy in Tinton Falls, to further extend the temporary cessation of all of Med Prep's pharmacy activities pending further examination into the cause of contamination found in magnesium sulfate products compounded by the company.
The Board of Pharmacy on Friday, March 15, entered into an initial Interim Voluntary Consent Order with Med Prep, under which the business agreed to temporarily halt all pharmacy operations until at least today. (See press release: www.njconsumeraffairs.gov/press/03152013.htm).
Under the terms of today's agreement, Med Prep has agreed to remain closed until at least April 5, while the State Division of Consumer Affairs and its Enforcement Bureau, in partnership with the State Department of Health, State Board of Pharmacy, U.S. Food and Drug Administration, and U.S. Centers for Disease Control and Prevention, continue to investigate the root cause of the contamination found in the Med Prep products.
Read the full release from the Office of the Attorney General
